FIELD: pharmacology.
SUBSTANCE: method for preparation of a sterile lyophilized drug based on the sodium salt of 5-amino-2,3-dihydrophthalazine-1,4-dione by processing an non-aqueous and/or double-aqueous non-sterile 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt is characterized by processing of an intermediate product of 5-amino-2,3-dihydrophthalazine-1,4-dione to obtain its sodium salt by dilution in an aqueous organic alkaline solution, such that the non-aqueous and/or double-aqueous substance of the 5-Amino-2,3-dihydrophthalazine-1,4-dione sodium salt is obtained by crystallisation at a temperature of minus 5-7°C from an aqueous organic solution of the 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, after which a sterile lyophilized drug is obtained from the substance.
EFFECT: obtained drugs influence the immune system and have immunomodulatory, anti-inflammatory, antitumor and antioxidant effects.
1 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING A MEDICINAL PRODUCT | 2020 |
|
RU2774615C1 |
METHOD OF OBTAINING LYOPHILISATE OF SODIUM AMINODIHYDROPHTHALAZINEDIONE, OR TAMERON MEDICATION | 2020 |
|
RU2744858C1 |
MEDICINAL AGENT | 2000 |
|
RU2163122C1 |
METHOD FOR PRODUCING A MEDICINAL PRODUCT | 2020 |
|
RU2774597C1 |
METHOD OF DRUG PRODUCING | 2000 |
|
RU2155043C1 |
PROCESS OF PRODUCTION OF MEDICINAL PREPARATION GALAVIT | 1999 |
|
RU2138264C1 |
DRUG BASED ON 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE AS QUICK-SOLUBLE FILM FOR TRANSBUCCAL INTRODUCTION | 2017 |
|
RU2635769C1 |
METHOD FOR PREPARING MEDICINAL PREPARATION | 2002 |
|
RU2222327C2 |
IMMUNOMODULATING AGENT | 1997 |
|
RU2113222C1 |
MEDICINAL PREPARATION (VARIANTS) AND METHOD FOR ITS PRODUCING | 2003 |
|
RU2233161C1 |
Authors
Dates
2017-07-12—Published
2016-09-22—Filed